BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1810053)

  • 1. [The treatment of protracted forms of Flexner dysentery].
    Iushchuk ND; Frolov VM; Peresadin NA
    Ter Arkh; 1991; 63(11):19-22. PubMed ID: 1810053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of quercetin and tocopherol acetate in treating patients with Flexner's dysentery].
    Frolov VM; Peresadin NA; Khomutianskaia NI; Pshenichnyĭ IIa
    Lik Sprava; 1993 Apr; (4):84-6. PubMed ID: 8209460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunomodulating effect of sodium nucleinate in chronic infectious-allergic urticaria].
    Zemskov VM; Poroshina IuA; Luss LV; Belostotskaia OI; Mikheeva GN
    Ter Arkh; 1990; 62(9):111-6. PubMed ID: 2281392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RNA as a modulator of secondary immunological deficiency and dysnucleotidosis].
    Zemskov AM; Zemskov VM; Perederiĭ VG; Borisova AM; Provotorov VM
    Antibiotiki; 1982; 27(9):704-10. PubMed ID: 7149695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic efficacy of sodium nucleinate and monoribonucleotides based on keratoconjunctival test data].
    Zemskov AM; Trutnev BD; Popova VP; Salomakhin GG; Dolzhanov AIa; Mikstaĭs IuIa
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):71-4. PubMed ID: 8067149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinico-pathogenetic significance of disorders of the immune status in dysentery].
    Iushchuk ND; Frolov VM; Peresadin NA; Kalender SD
    Ter Arkh; 1990; 62(11):36-9. PubMed ID: 2094988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of sodium nucleinate in acute dysentery in children].
    Ionusova KhA; Shoiinov M; Nazarov Sh
    Pediatriia; 1982 Dec; (12):42-3. PubMed ID: 7162888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Humoral and cellular immunity in patients with acute dysentery].
    Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
    Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiotiki; 1984 Feb; 29(2):132-5. PubMed ID: 6703667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of combined immunomodulatory therapy with timoptin and sodium nucleinate in patients with chronic obstructive bronchitis].
    Zemskov AM; Zemskov VM; Nikitin AV; Zazhireĭ VD; Evstratova EF
    Ter Arkh; 1989; 61(3):65-8. PubMed ID: 2741121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of severe dysentery].
    Shakhmardanov MZ; Luchshev VI; Isaeva NP; Bondarenko VM
    Klin Med (Mosk); 1997; 75(11):69-71. PubMed ID: 9490365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of sodium nucleinate in treating periodontosis].
    Zemskov MV; Zemskov VM; Gurina ZA; Nerobeev AI
    Stomatologiia (Mosk); 1982; (2):23-5. PubMed ID: 6953626
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immune status indices of children with atopic dermatitis during sodium nucleinate therapy].
    Mazina NM; Avdeeva ZhI; Mannanov AM
    Vestn Dermatol Venerol; 1990; (10):45-9. PubMed ID: 2278195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of sodium nucleinate in clinical practice].
    Keleberda KIa; Baranova TV
    Probl Tuberk; 1988; (8):69-72. PubMed ID: 3059344
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined immunocorrection--a prospective method for treating secondary immunodeficiency].
    Perederiĭ VG; Zemskov AM; Provotorov VM; Nikitin AV; Evstratova EF
    Vrach Delo; 1989 Jan; (1):96-8. PubMed ID: 2718463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospects for using thymalin in treating bacterial intestinal infections].
    Ivanov KS; Boĭko IN; Bilyk AI; Khavinson VKh
    Voen Med Zh; 1987 Aug; (8):38-9. PubMed ID: 3314133
    [No Abstract]   [Full Text] [Related]  

  • 17. [The tocopherol acetate and splenin correction of the immunological disorders in patients with viral hepatitis B].
    Frolov VM; Peresadin NA; Dekaliuk IV; Pshenichnyĭ IIa
    Lik Sprava; 1992 Apr; (4):90-1. PubMed ID: 1441392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhanced effectiveness of antibiotic therapy with an exogenous lysozyme in dysentery in children].
    Vereshchagin IA; Vereshchagin SI; Zhuravleva OD
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):927-31. PubMed ID: 3936408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoactive drugs in the combined modality therapy of patients with hypothyroidism].
    Epishin AV; Grytsiv VE; Venger EP
    Ter Arkh; 1991; 63(2):88-92. PubMed ID: 2048033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.